Three new publicly traded device companies are expected to enter the market in the next one to two years, according to announcements from Zimmer Biomet, Johnson & Johnson and Colfax Corp.:
Spinal Tech
Johnson & Johnson is dividing into two separate companies; one will focus on its medical devices and drugs, and the other will focus on consumer health products.
From Johnson & Johnson's latest robotics acquisition to NuVasive's acquisition of an emerging spine technology, here are six medtech deals that caught the eye of readers in 2021.
From the CFO of Zimmer Biomet's spine and dental spinoff to MicroPort Orthopedics' medical director, here are eight leadership moves since Sept. 12:
Linnea Burman, vice president and general manager of Medtronic's enabling technology business, was recognized as Innovator of the Year by the National Spine Health Foundation.
Advertisement
From third-quarter financial reports to Johnson & Johnson's latest orthopedic acquisition, here are seven key updates from spine and orthopedic device companies in the last week:
David Dvorak, who previously led Zimmer Biomet, was named executive chair of the board of directors at medical device company Think Surgical, according to a Nov. 10 news release.
NuVasive's net sales were affected in part by challenges with the COVID-19 pandemic and elective surgery halt, according to third-quarter financial results posted Nov. 9.
Devicemaker Arthrex agreed to pay $16 million to resolve kickback allegations involving a Colorado orthopedic surgeon, the U.S. Justice Department said Nov. 8.
Alphatec, Globus Medical and SeaSpine posted their third-quarter financial reports, and all of them saw increased revenues year over year.